We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.33%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$152B
AUM Growth
+$4.77B
Cap. Flow
+$2.89B
Cap. Flow %
1.9%
Top 10 Hldgs %
26.78%
Holding
4,133
New
185
Increased
1,882
Reduced
1,701
Closed
184

Top Buys

Rank Stock Value
1
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$255M
2
AAPL icon
Apple
AAPL
+$184M
3
NEE icon
NextEra Energy
NEE
+$153M
4
WMT icon
Walmart Inc
WMT
+$141M
5
PEG icon
Public Service Enterprise Group
PEG
+$119M

Top Sells

Rank Stock Value
1
XLV icon
State Street Health Care Select Sector SPDR ETF
XLV
+$157M
2
PXD
Pioneer Natural Resource Co.
PXD
+$110M
3
NVDA icon
NVIDIA
NVDA
+$90.1M
4
VST icon
Vistra
VST
+$72.2M
5
UNP icon
Union Pacific
UNP
+$58.5M

Sector Composition

Rank Sector Weight
1 Technology 17.11%
2 Financials 8.61%
3 Healthcare 7.69%
4 Industrials 6.49%
5 Consumer Discretionary 5.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PSNY icon
3851
Polestar Automotive Holding UK
PSNY
$2.01B
$16.2K ﹤0.01%
688
-333
-33% -$11.1K
VIVS
3852
VivoSim Labs
VIVS
$1.27M
$15K ﹤0.01%
1,635
-17
-1% -$201
BFI
3853
DELISTED
BurgerFi International, Inc. Common Stock
BFI
$14.6K ﹤0.01%
71,881
– –
NMTC icon
3854
NeuroOne Medical Technologies
NMTC
$13.6M
$13.9K ﹤0.01%
+2,900
New +$18.2K
NXG.RT
3855
DELISTED
NXG NextGen Infrastructure Income Fund Rights (expiring July 17, 2024)
NXG.RT
$12.5K ﹤0.01%
+22,738
New +$13K
VXRT
3856
DELISTED
Vaxart
VXRT
$11.2K ﹤0.01%
16,726
-131
-0.8% -$109
ADAP
3857
DELISTED
Adaptimmune Therapeutics
ADAP
$9.96K ﹤0.01%
+10,218
New +$11.2K
SKYX icon
3858
SKYX Platforms
SKYX
$164M
$9.5K ﹤0.01%
10,000
– –
VMAR icon
3859
Vision Marine Technologies
VMAR
$3.94M
– –
0
– –
FTH
3860
Faeth Therapeutics
FTH
$736M
$8.68K ﹤0.01%
700
– –
MLSS icon
3861
Milestone Scientific
MLSS
$42M
$8.2K ﹤0.01%
12,000
– –
KULR icon
3862
KULR Technology Group
KULR
$127M
$7.98K ﹤0.01%
+2,526
New +$9.05K
SENS icon
3863
Senseonics Holdings Inc
SENS
$399M
$7.86K ﹤0.01%
985
-344
-26% -$3.06K
EVA
3864
DELISTED
Enviva Inc.
EVA
$6.91K ﹤0.01%
16,066
+150
+0.9% +$75
DWTX
3865
Dogwood Therapeutics
DWTX
$61.5M
$6.45K ﹤0.01%
1,200
– –
HELP
3866
Cybin Inc
HELP
$620M
$6.27K ﹤0.01%
609
+6
+1% +$79
GORO icon
3867
Goldgroup Mining Inc.
GORO
$186M
$6.09K ﹤0.01%
+16,308
New +$7.96K
GEVO icon
3868
Gevo
GEVO
$388M
$5.96K ﹤0.01%
10,700
– –
SOAR icon
3869
Volato Group
SOAR
$9.08M
$5.85K ﹤0.01%
400
– –
JOB icon
3870
GEE Group
JOB
$22.1M
$5.52K ﹤0.01%
18,000
– –
SGMO
3871
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$4.75K ﹤0.01%
13,250
-700
-5% -$378
MVST icon
3872
Microvast
MVST
$291M
$4.56K ﹤0.01%
+10,000
New +$4.49K
PPBT
3873
Purple Biotech
PPBT
$2.44M
$4.07K ﹤0.01%
50
– –
AZ icon
3874
A2Z Smart Technologies
AZ
$288M
$3.98K ﹤0.01%
4,000
– –
AKTS
3875
DELISTED
Akoustis Technologies Inc
AKTS
$2.81K ﹤0.01%
21,316
– –
153 154
155
156 157

Similar funds

RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
ECU
Eisler Capital (UK) London, United Kingdom $21.7B AUM 0.34% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
AA
Axiom Advisory San Diego, California $10.7B AUM 25.51% 1-Year Est. Return
SA
SpiderRock Advisors Wilimington, Delaware $6.29B AUM
WPL
Winder Pte Ltd Singapore $5.59B AUM 41.5% 1-Year Est. Return
ECU
Eisler Capital (US) New York $4.67B AUM 35.2% 1-Year Est. Return

Raymond James & Associates's Q2 2024 Portfolio in Review

As of Q2 2024, Raymond James & Associates held 4,133 positions worth $152B, up 3.2% from $148B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Raymond James & Associates's Q2 2024 filing shows 185 new, 1,882 increased, 1,701 reduced and 184 closed positions. Its largest new stake was Solventum: 321,226 shares worth $17M. The largest sale was State Street Health Care Select Sector SPDR ETF, an estimated $157M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2024 buy was Solventum: 321,226 shares worth $17M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q2 2024, an estimated $255M increase.
  • Raymond James & Associates's biggest Q2 2024 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $157M.
  • Raymond James & Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $110M.
  • Raymond James & Associates's ten largest holdings make up 27% of its $152B portfolio in Q2 2024.
  • Raymond James & Associates opened 185 new positions and closed 184 in Q2 2024.
  • Raymond James & Associates's portfolio value rose 3.2% quarter-over-quarter to $152B.

Based on Raymond James & Associates's 13F filing for Q2 2024, filed 19 Jul 2024.